Cannabis in pregnancy: What brain scans reveal—and what's still unclear

Investigating Links Between Prenatal Cannabis Exposure and Brain Development Using Magnetic Resonance Imaging Techniques: A Narrative Review.

Biological psychiatry global open science • • Review • Highly Relevant
🤖

AI Summary

This narrative review examines recent research on how prenatal cannabis exposure (PCE) affects fetal and childhood brain development, analyzing studies published after 2019 that used advanced brain imaging techniques. Researchers reviewed 9 studies using MRI technology to track brain changes from pregnancy through adolescence, finding that PCE was associated with differences in frontal, parietal, and temporal brain regions—areas critical for decision-making, sensory processing, and memory. The findings suggest potential impacts across multiple stages of development, but importantly, the research reveals no consistent pattern yet about exactly how cannabis exposure shapes the developing brain.

The review highlights significant limitations in current research that complicate drawing firm conclusions. Scientists face challenges including varying methods of measuring cannabis use (self-report versus biological testing), difficulty isolating the effects of cannabis from other prenatal exposures, and incomplete information about timing, frequency, potency, and consumption method. Additionally, only 3 of the 9 studies examined both brain imaging and actual behavioral outcomes, making it difficult to understand whether observed brain differences translate to real-world developmental consequences. The authors stress that parental and postnatal factors—such as childcare environment and parenting style—weren't adequately controlled for in most studies.

The authors call for more rigorous future research with standardized assessment methods and designs that can capture the complexity of real-world cannabis use during pregnancy. Such research is increasingly urgent given rising cannabis use among pregnant individuals and changing legal/social attitudes toward cannabis. Only through better-designed studies can we understand whether prenatal cannabis exposure causes lasting effects on child development or whether observed brain imaging differences have meaningful health implications for growing children.

💡 Key Findings

1
Prenatal cannabis exposure is linked to structural differences in frontal, parietal, and temporal brain regions spanning from in utero development through adolescence across multiple MRI imaging types.
Good
70%
2
No consistent pattern has emerged across the 9 reviewed studies regarding how cannabis affects specific brain structures, making it premature to draw firm conclusions about developmental impacts.
High
85%
3
Only 3 of 9 studies examined both brain imaging AND behavioral outcomes, limiting understanding of whether observed brain differences translate to actual developmental or cognitive consequences.
High
90%
4
Research inconsistencies stem from varying measurement methods (self-report vs. urine testing), incomplete data on cannabis potency, timing, and consumption mode, and inadequate control for other prenatal exposures and postnatal environmental factors.
High
90%
5
Future studies must implement standardized, rigorous designs capturing cannabis use details alongside parental and environmental factors to enable replication and meta-analyses on this increasingly important public health topic.
High
85%

📄 Original Abstract

Understanding the impact of prenatal cannabis exposure (PCE) on brain development is increasingly important given rising cannabis use during pregnancy. Many existing reviews on this topic are more than 5 years old and may not reflect recent social shifts that could impact cannabis use during pregnancy; they also have not utilized the recently available large longitudinal datasets for more robust and population-representative investigations. In this narrative review, we aim to provide an updated and expanded examination of the associations between PCE and magnetic resonance imaging (MRI)-based brain outcomes from in utero development to adolescence. We included studies published after 2019 that used at least one of the following measures: structural MRI, diffusion-weighted imaging, resting-state fMRI, and/or task-based fMRI. Across 9 studies that met criteria, 1 study focused on MRI outcomes in utero, 2 in infancy, and 6 in early adolescence, and only 3 studies included MRI and behavior outcomes. PCE was linked to differences in frontal, parietal, and temporal areas, spanning from in utero to adolescence across multiple MRI modalities. However, in the current state of the literature, detecting a consistent trend on PCE's impact on MRI findings was not possible. Furthermore, we found several divergences in study design: varying approaches to assessment (e.g., self-report vs. urine toxicology); difficulties in accounting for prenatal exposure to multiple substances; limited information on timing, frequency, potency, or mode of consumption; and the influence of parental or postnatal factors. Future research should implement designs that can rigorously capture the abovementioned elements to permit replication and eventual meta-analyses on this critical topic.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.